Boehringer Ingelheim Vetemedica Inc. (BIVI) has introduced a new vaccine for equine rhinitis A virus (ERAV), a sometimes overlooked causative agent of respiratory diseases affecting horses.

This disease, which affects both upper and lower airways, can be spread by contact through nasal secretions and aerosol inhalation.

"We are excited to offer a safe vaccine option for veterinarians and horse owners," said John Tuttle, DVM, senior associate director of equine professional and technical services. "As a worldwide leader in equine health-care solutions, we also have an obligation to help educate the industry about the prevalence, diagnosis and treatment of this disease